• Normal font size
  • Large font size
  • High contrast layout
Skip to Main content Home | Gaeilge | Site Map
Houses of the Oireachtas - Tithe an Oireachtas
Contact
Mobile

  • About
  • TDs & Senators
  • Oireachtas Business
  • Visits & Events
  • Watch & Listen
  • Media Zone
  • Education
Home > Debates > Dáil > 2003
  • Debates
  • Dáil Debates
  • Seanad Debates
  • Committee Debates
  • Search Debates
  • RSS Feeds
  • Members Database

  • Contents
  • Index
  • Questions
  • Speakers
  • Print All

  • Index for May
  • Speakers for May
  • Index for 2003
  • Speakers for 2003

Written Answers. - Medicinal Products.

Tuesday, 27 May 2003

Dáil Eireann Debate
Vol. 567 No. 5

First Page Previous Page Page of 288 Next Page Last Page

  313.  Ms O. Mitchell  Information on Olivia Mitchell  Zoom on Olivia Mitchell   asked the Minister for Health and Children  Information on Micheál Martin  Zoom on Micheál Martin   the current status of kava kava as a medicine; if it has Irish Medicines Board recognition; if it is eligible under the GMS; and if his attention has been drawn to doctors prescribing same. [14341/03]

Minister for Health and Children (Mr. Martin): Information on Micheál Martin  Zoom on Micheál Martin  A common list of reimbursable medicines was introduced for the general medical services scheme, GMS, and the drug payment scheme, DPS. This list ensures equity between the GMS and DPS in relation to the range of medicines paid for by the State under both schemes. The common list is subject to ongoing review and amendment on a monthly basis, as new products become available and deletions are notified.

For any item to be included in the common list, it must comply with a published list of criteria. These include authorisation status where appropriate, price and, in certain cases, the intended use of the product. In addition, the product should ordinarily be supplied to the public only by medical prescription and should not be advertised or promoted to the public. Kava kava is not an authorised medicine in this country and is at present the subject of a voluntary withdrawal by the industry at the request of the Irish Medicines Board due to concerns over liver damage.


Last Updated: 10/09/2010 14:46:13 First Page Previous Page Page of 288 Next Page Last Page
 

About

  • Dail
  • Seanad
  • History
  • Committees
  • Houses Commission
  • Publications
  • Library & Research Service
  • Careers
  • Contact
  • European Union
  • Administration
  • Freedom of Information

TDs & Senators

  • Office Holders
  • TDs
  • Senators
  • Dáil Register
  • General Elections and Seanad Elections
  • Parliamentary Standard Allowance
  • Register of Members Interests
  • Register of Political Parties
  • Members Login

Oireachtas Business

  • Order Papers
  • Debates & Publications
  • Bills & Legislation
  • Committees
  • Weekly Agenda
  • Parliamentary Questions
  • Budget 2010

Visits & Events

  • Visit Leinster House
  • Visitors Brochures
  • Oireachtas Short Film Series
  • Directions
  • Feedback
  • Events

Watch & Listen

  • Watch
  • Listen

Media Zone

  • Press Releases
  • Press Release Archive
  • Accreditation
  • Factsheet
  • Facilities
  • Media Press Office
  • Party Press Offices

Education

  • Historical Debates and Speeches
  • Games
  • Glossary

www.Oireachtas.ie

Office of the Houses of the Oireachtas, Leinster House, Dublin 2. Ph: +353 1 618 3000

Freedom of Information - Government Website - Privacy Policy - Accessibility